Pass-Through Device Applications:CMS received 14 complete pass-through device applications by the March 1, 2024 quarterly deadline. Of these, 10 had received Breakthrough Device designation and U.S. Food and Drug Administration (FDA) marketing authorization, making them eligible to apply under ...